Treatment of isoniazid-resistant pulmonary tuberculosis

被引：0
|
作者：
Yee Hyung Kim
Gee Young Suh
Man Pyo Chung
Hojoong Kim
O Jung Kwon
Seong Yong Lim
Si Young Lim
Won-Jung Koh
机构：
[1] Sungkyunkwan University School of Medicine,Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center
[2] Sungkyunkwan University School of Medicine,Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kangbuk Samsung Hospital
来源：
BMC Infectious Diseases | / 8卷
关键词：
Treatment Failure; American Thoracic Society; Sputum Smear; Directly Observe Therapy; British Thoracic Society;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Case report: A 9-year systematic treatment failure of a pulmonary tuberculosis patient
    Jiang, Hui
    Zhu, Chendi
    Qin, Liyi
    Wu, Xiaoguang
    Yin, Jinfeng
    Guo, Yijia
    Ma, Huan
    Jia, Junnan
    Huo, Fengmin
    Xue, Yi
    Gao, Mengqiu
    Li, Weimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [32] Changes in the levels of adipokines in newly diagnosed pulmonary tuberculosis patients in case of treatment failure
    Yasinskyi, R. M.
    Raznatovska, O. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (02) : 220 - 225
  • [33] Long-term survival of patients with multidrug-resistant tuberculosis according to treatment outcomes
    Kwak, Nakwon
    Yoo, Chul-Gyu
    Kim, Young Whan
    Han, Sung Koo
    Yim, Jae-Joon
    AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (07) : 843 - 845
  • [34] Treatment Outcomes of Multidrug-Resistant Tuberculosis in Taiwan: Tackling Loss to Follow-up
    Yu, Ming-Chih
    Chiang, Chen-Yuan
    Lee, Jen-Jyh
    Chien, Shun-Tien
    Lin, Chou-Jui
    Lee, Shih-Wei
    Lin, Chih-Bin
    Yang, Wen-Ta
    Wu, Ying-Hsun
    Huang, Yi-Wen
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (02) : 202 - 210
  • [35] Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment
    Coronel, J.
    Roper, M. H.
    Herrera, C.
    Bonilla, C.
    Jave, O.
    Gianella, C.
    Sabogal, I.
    Huancare, V.
    Leo, E.
    Tyas, A.
    Mendoza-Ticona, A.
    Caviedes, L.
    Moore, D. A. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (06) : 536 - 541
  • [36] Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine
    Aibana, Omowunmi
    Bachmaha, Mariya
    Krasiuk, Viatcheslav
    Rybak, Natasha
    Flanigan, Timothy P.
    Petrenko, Vasyl
    Murray, Megan B.
    BMC INFECTIOUS DISEASES, 2017, 17
  • [37] Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan
    Makhmudova, M.
    Maxsumova, Z.
    Rajabzoda, A.
    Makhmadov, A.
    van den Hof, S.
    Mirtskhulava, V.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (03) : 331 - +
  • [38] Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study
    Sanchez-Padilla, E.
    Marquer, C.
    Kalon, S.
    Qayyum, S.
    Hayrapetyan, A.
    Varaine, F.
    Bastard, M.
    Bonnet, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (02) : 160 - 167
  • [39] Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
    Payam Nahid
    Leah G Jarlsberg
    Irina Rudoy
    Bouke C de Jong
    Alon Unger
    L Masae Kawamura
    Dennis H Osmond
    Philip C Hopewell
    Charles L Daley
    BMC Infectious Diseases, 11
  • [40] A LONGITUDINAL STUDY TO KNOW RISK FACTORS RELATED WITH TREATMENT FAILURE IN PATIENTS OF PULMONARY TUBERCULOSIS WITH POSITIVE SMEAR AND THEIR TREATMENT OUTCOME
    Hoor, Shahana
    Ghouri, Zohaib
    Taha, Hassan
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (09): : 8635 - 8639
12345